Asensus Surgical Investor Relations Material

Asensus Surgical Inc. is a medical device company focused on developing and commercializing robotic-assisted surgical systems. Its flagship product, the Senhance Surgical System, uses augmented intelligence to enhance precision and control in minimally invasive surgeries. The company's technology is designed to improve surgeon performance, reduce variability in procedures, and enhance patient outcomes by integrating advanced robotics with digital capabilities. The company is headquartered in Durham, North Carolina, and its shares are listed on the NYSE.